FDA recommends thyroid monitoring in babies and young children who receive injections of iodine-containing contrast media for medical imaging

Based on our recent review of published studies, FDA is recommending that newborns and children through 3 years old have follow-up thyroid monitoring within 3 weeks after receiving injections of contrast media containing iodine for X-rays and other medical imaging procedures.

Source: FDA Center for Drug Evaluation and Research - What's New - March 30, 2022 Category: Drugs & Pharmacology Authors: FDA Source Type: news